Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymopentin for reducing post-chemotherapy infection in lymphoma
ChiCTR-PRC-08000109Phase 4Recruiting
- Sponsor
- Fujian Medical University Cancer Hospital
- Start
- Jan 2008
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of thymopentin in non-Hodgkin lymphoma (NHL) (2 arms), sponsored by Fujian Medical University Cancer Hospital. Primary endpoint: White cell count. Started Jan 2008; status: recruiting.
02
Drugs
thymopentin
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on ChiCTR-PRC-08000109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-PRC-08000109.